H4C3
HC-030031 |
|||
B2100-50 | ApexBio | 50 mg | 234 EUR |
Description: HC-030031 is a selective antagonist of transient receptor potential ankyrin subfamily, member 1(TRPA1) with IC50 value of 4.9?M [1].TRP channels are found to take participate in the response of chemical stimuli and in mechanoreception. |
|||
HC-030031 |
|||
20-abx076575 | Abbexa |
|
|
HC-056456 |
|||
HY-112729 | MedChemExpress | 25mg | 362.4 EUR |
HC-030031 |
|||
HY-15064 | MedChemExpress | 100mg | 357.6 EUR |
HC-067047 |
|||
HY-100208 | MedChemExpress | 10mg | 224.4 EUR |
HC-056456 |
|||
T4604-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: HC-056456 |
|||
HC-056456 |
|||
T4604-1g | TargetMol Chemicals | 1g | Ask for price |
Description: HC-056456 |
|||
HC-056456 |
|||
T4604-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: HC-056456 |
|||
HC-056456 |
|||
T4604-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: HC-056456 |
|||
HC-056456 |
|||
T4604-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: HC-056456 |
|||
HC-067047 |
|||
T4680-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: HC-067047 |
|||
HC-067047 |
|||
T4680-1g | TargetMol Chemicals | 1g | Ask for price |
Description: HC-067047 |
|||
HC-067047 |
|||
T4680-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: HC-067047 |
|||
HC-067047 |
|||
T4680-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: HC-067047 |
|||
HC-067047 |
|||
T4680-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: HC-067047 |
|||
HC-030031 |
|||
522647 | MedKoo Biosciences | 10.0mg | 250 EUR |
HC-067047 |
|||
530432 | MedKoo Biosciences | 5.0mg | 250 EUR |
HC-056456 |
|||
531948 | MedKoo Biosciences | 10.0mg | 120 EUR |
HC-030031 |
|||
T6530-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: HC-030031 |
|||
HC-030031 |
|||
T6530-1g | TargetMol Chemicals | 1g | Ask for price |
Description: HC-030031 |
|||
HC-030031 |
|||
T6530-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: HC-030031 |
|||
HC-030031 |
|||
T6530-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: HC-030031 |
|||
HC-030031 |
|||
T6530-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: HC-030031 |
|||
HC-030031 (TRPA1 blocker) |
|||
SIH-303-10MG | Stressmarq | 10 mg | 172.8 EUR |
Description: The substance HC-030031 is a trpa1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO. |
|||
HC-030031 (TRPA1 blocker) |
|||
SIH-303-50MG | Stressmarq | 50 mg | 463.2 EUR |
Description: The substance HC-030031 is a trpa1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO. |
|||
HC067047 Hydrochloride(883031-03-6 free base) |
|||
T4680L-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: HC067047 Hydrochloride(883031-03-6 free base) |
|||
HC067047 Hydrochloride(883031-03-6 free base) |
|||
T4680L-1g | TargetMol Chemicals | 1g | Ask for price |
Description: HC067047 Hydrochloride(883031-03-6 free base) |
|||
HC067047 Hydrochloride(883031-03-6 free base) |
|||
T4680L-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: HC067047 Hydrochloride(883031-03-6 free base) |
|||
HC067047 Hydrochloride(883031-03-6 free base) |
|||
T4680L-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: HC067047 Hydrochloride(883031-03-6 free base) |
|||
HC067047 Hydrochloride(883031-03-6 free base) |
|||
T4680L-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: HC067047 Hydrochloride(883031-03-6 free base) |
|||
Roller Base (HC34, HC35 & VHC35) |
|||
TW-R033-8C00 | MiTeGen | 1 UNIT | 331 EUR |
Description: Roller Base (HC34, HC35 & VHC35) |
|||
HC-070 |
|||
HY-112302 | MedChemExpress | 5mg | 542.4 EUR |
HC-070 |
|||
T15465-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: HC-070 |
|||
HC-070 |
|||
T15465-1g | TargetMol Chemicals | 1g | Ask for price |
Description: HC-070 |
|||
HC-070 |
|||
T15465-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: HC-070 |
|||
HC-070 |
|||
T15465-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: HC-070 |
|||
HC-070 |
|||
T15465-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: HC-070 |
|||
Cryo-Sentry Level Alarm (HC20 & HC34) |
|||
TW-R034-8C15 | MiTeGen | 1 UNIT | 1215 EUR |
Description: Cryo-Sentry Level Alarm (HC20 & HC34) |
|||
BMS 599626 2HCl (873837-23-1(HCl)) |
|||
T5398-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BMS 599626 2HCl (873837-23-1(HCl)) |
|||
BMS 599626 2HCl (873837-23-1(HCl)) |
|||
T5398-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BMS 599626 2HCl (873837-23-1(HCl)) |
|||
BMS 599626 2HCl (873837-23-1(HCl)) |
|||
T5398-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BMS 599626 2HCl (873837-23-1(HCl)) |
|||
BMS 599626 2HCl (873837-23-1(HCl)) |
|||
T5398-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BMS 599626 2HCl (873837-23-1(HCl)) |
|||
BMS 599626 2HCl (873837-23-1(HCl)) |
|||
T5398-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BMS 599626 2HCl (873837-23-1(HCl)) |
|||
Anti-SNRPG (2H8-1C12) |
|||
YF-MA15517 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to SNRPG |
|||
Anti-ZMAT4 (7H3-1C11) |
|||
YF-MA19341 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to ZMAT4 |
|||
Anti-EIF2S1 (3H12-C11) |
|||
YF-MA10267 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to EIF2S1 |
|||
H9c2 (2-1) |
|||
ABC-TC0286 | AcceGen | 1 vial | Ask for price |
Description: Rat BDIX heart myoblast. Skeletal muscle properties. Myotubes formed at confluency respond to acetylcholine. Differentiation improved by reducing serum concentration to 1%. |
|||
HC11 |
|||
C0006035 | Addexbio | One Frozen vial | 470 EUR |
Monoclonal CRY1 Antibody (clone 4H4-1C4), Clone: 4H4-1C4 |
|||
APR11687G | Leading Biology | 0.05mg | 633.6 EUR |
Description: A Monoclonal antibody against Human CRY1 (clone 4H4-1C4). The antibodies are raised in Mouse and are from clone 4H4-1C4. This antibody is applicable in WB and IHC-P, IF, E |
|||
anti-Nucleobindin 1 (1H8-2C11) |
|||
LF-MA10212 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to Nucleobindin 1 |
|||
Hemagglutinin Antibody [4H1C10] |
|||
PM-4006-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Hemagglutinin Monoclonal Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. The more recent virulent strain of H5N1 is now seen in Africa and Europe, as well as in southeast Asia. There is some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. While efforts were made to use relatively conserved regions of the viral sequence as the antigen, the influenza virus genome has drifted somewhat from what was first reported. However, this antibody was able to recognize peptides derrived from viruses from Indonesian human patients infected in 2007. |
|||
Hemagglutinin Antibody [4H1C10] |
|||
PM-4006-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Hemagglutinin Monoclonal Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. The more recent virulent strain of H5N1 is now seen in Africa and Europe, as well as in southeast Asia. There is some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. While efforts were made to use relatively conserved regions of the viral sequence as the antigen, the influenza virus genome has drifted somewhat from what was first reported. However, this antibody was able to recognize peptides derrived from viruses from Indonesian human patients infected in 2007. |
|||
H9c2(2-1) cells |
|||
C0031002 | Addexbio | One Frozen vial | 546 EUR |
Monoclonal TERT Antibody, Clone: 3H2C12 |
|||
AMM03045G | Leading Biology | 0.1ml | 633.6 EUR |
Description: A Monoclonal antibody against Human TERT. The antibodies are raised in Mouse and are from clone 3H2C12. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
H9c2(2-1) Cell Line |
|||
CL-0089 | Elabscience Biotech | 1×10⁶ cells/vial | 420 EUR |
Description: Rattus norvegicus, Rat |
|||
HC11 cell line |
|||
CL-0616 | Elabscience Biotech | 1×10⁶ cells/vial | 500 EUR |
Description: Homo sapiens, human |
|||
Monoclonal PLCG1 Antibody, Clone: 3H1C10 |
|||
AMR09347G | Leading Biology | 0.1ml | 633.6 EUR |
Description: A Monoclonal antibody against Human PLCG1. The antibodies are raised in Mouse and are from clone 3H1C10. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal Rab5a Antibody, Clone: 3H5C11 |
|||
APR13050G | Leading Biology | 0.1ml | 633.6 EUR |
Description: A Monoclonal antibody against Human Rab5a. The antibodies are raised in Mouse and are from clone 3H5C11. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal PLA2G12A Antibody, Clone: 3H2C11 |
|||
APR12888G | Leading Biology | 0.1ml | 633.6 EUR |
Description: A Monoclonal antibody against Human PLA2G12A. The antibodies are raised in Mouse and are from clone 3H2C11. This antibody is applicable in WB and IHC, FC, E |
|||
Monoclonal IL1RAPL1 Antibody, Clone: 2H3C12 |
|||
APG03380G | Leading Biology | 0.1ml | 633.6 EUR |
Description: A Monoclonal antibody against Human IL1RAPL1. The antibodies are raised in Mouse and are from clone 2H3C12. This antibody is applicable in WB and IHC, FC, ICC, E |